Last updated on May 2019

Safety and Efficacy of 2 Treatment Regimens of Aztreonam for Inhalation Solution in Children With Cystic Fibrosis and New Onset Pseudomonas Aeruginosa Infection


Brief description of study

The primary objective of this study is to evaluate the safety and efficacy of a 14-day course versus a 28-day course of aztreonam for inhalation solution (AZLI) in participants with new onset Pseudomonas aeruginosa respiratory tract infection.

Clinical Study Identifier: NCT03219164

Find a site near you

Start Over

Medical College of Georgia

Augusta, GA United States
  Connect »

Corner Children's Hospital

Chicago, IL United States
  Connect »

LSUHSC - Sheveport

Shreveport, LA United States
  Connect »

Children's Healthcare

Minneapolis, MN United States
  Connect »

New York Medical College

Hawthorne, NY United States
  Connect »

Clinical Research of Charlotte

Charlotte, NC United States
  Connect »

Cleveland Clinic

Cleveland, OH United States
  Connect »

Cook Children's Medical Center

Fort Worth, TX United States
  Connect »

University of Utah

Salt Lake City, UT United States
  Connect »

UZ Antwerpen

Edegem, Belgium
  Connect »

Rigshospitalet

Copenhagen, Denmark
  Connect »

Erasmus MC

Rotterdam, Netherlands
  Connect »

Hospital Sant Joan de Deu

Esplugues de Llobregat, Spain
  Connect »

NHS Grampian

Aberdeen, United Kingdom
  Connect »

NHS tayside

Dundee, United Kingdom
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.